On March 11, 2022, Douglas A. Roeder, notified Tandem Diabetes Care, Inc. of his decision not to stand for re-election at the Company's 2022 Annual Meeting of Stockholders (the 2022 Annual Meeting). Mr. Roeder has served on the Board since May 2009 and is currently serving as a Class III director with a term that will end concurrent with the 2022 Annual Meeting. The decision by Mr. Roeder not to stand for re-election did not involve a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.57 USD | -0.61% |
|
-6.34% | +43.91% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.91% | 2.77B | |
-3.18% | 181B | |
-2.68% | 105B | |
-2.23% | 67.55B | |
-6.46% | 46.39B | |
+6.18% | 40.93B | |
+20.09% | 31.63B | |
+11.53% | 24.28B | |
-6.67% | 23.46B | |
-12.70% | 21.95B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Announces That Douglas A. Roeder Notified His Decision Not to Stand for Re-Election